Healthcare venture capital firms reap rewards when working with corporate venturing peers.
The view from the venture capitalists is that the healthcare industry has found a way for people to avoid death but not yet how to charge for the service.
That, according to Anton Gueth, managing director of merchant banking at US-based Burrill & Co, which manages more than $1bn in life sciences venture capital funds, is why there is so much innovation both in therapeutics and business models.
Gueth said at the BioEurope 2010 conference in Spain: “Funding…
